Key facts
- This page summarizes Ngai Hang Victor Chong's Form 4 filing for Clearside Biomedical, Inc. (CLSD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Nov 2024, 16:15.
Ngai Hang Victor Chong - 01 Nov 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- CLSD
- Reported as of
- 01 Nov 2024
- Net transaction value
- +$36,500
- SEC form
- 4
- Accepted by SEC
- 04 Nov 2024, 16:15:04 UTC
- Prior SEC filing
- 24 Jun 2024
- Next SEC filing
- 10 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Ballantyne, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ngai Hang Victor Chong filed Form 4 for Clearside Biomedical, Inc. (CLSD) on 04 Nov 2024.
Change
- Previous filing in this sequence was filed on 24 Jun 2024.
- Current net transaction value: +$36,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLSD
transaction
Common Stock
Purchase
- Transaction value
- $36,500
- Shares
- +36,500
- Change %
- +57%
- Price
- $1.00
- Shares after
- 100,000
- Date
- 01 Nov 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.